Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar in Vitro

NCT05640687 is registered in ClinicalTrials.gov with Guangzhou Institute of Respiratory Disease as lead sponsor.

NCT NCT05640687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05640687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Mesenchymal Stem Cells Treat Autoimmune Pulmonary Alveolar in Vitro
Lead sponsor
Guangzhou Institute of Respiratory Disease
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2021
Completion date
April 6, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary alveolar proteinosis(pap)